24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients
- PMID: 11866304
- DOI: 10.1111/j.1572-0241.2002.05512.x
24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients
Comment on
-
Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response.Am J Gastroenterol. 2001 Apr;96(4):1237-42. doi: 10.1111/j.1572-0241.2001.03631.x. Am J Gastroenterol. 2001. PMID: 11316176 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources